In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under ...

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

Dartmouth hospital CFO details 340B designation risk and strategic partnership to safeguard federal program participation at ...

Illinois is facing an intense battle over a federal program requiring drug manufacturers to sell deeply discounted ...

(The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to a ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...